Correlation Between 23Andme Holding and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and ProMIS Neurosciences, you can compare the effects of market volatilities on 23Andme Holding and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and ProMIS Neurosciences.
Diversification Opportunities for 23Andme Holding and ProMIS Neurosciences
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and ProMIS is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between 23Andme Holding and ProMIS Neurosciences
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the ProMIS Neurosciences. But the stock apears to be less risky and, when comparing its historical volatility, 23Andme Holding Co is 1.04 times less risky than ProMIS Neurosciences. The stock trades about -0.61 of its potential returns per unit of risk. The ProMIS Neurosciences is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 102.00 in ProMIS Neurosciences on November 9, 2024 and sell it today you would lose (5.00) from holding ProMIS Neurosciences or give up 4.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. ProMIS Neurosciences
Performance |
| Timeline |
| 23Andme Holding |
| ProMIS Neurosciences |
23Andme Holding and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and ProMIS Neurosciences
The main advantage of trading using opposite 23Andme Holding and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |